A Serum MicroRNA Panel as Potential Biomarkers for Hepatocellular Carcinoma Related with Hepatitis B Virus
作者： Youwen Tan , Guohong Ge , Tengli Pan , Danfeng Wen , Li Chen
DOI: 10.1371/JOURNAL.PONE.0107986
关键词:
摘要: Background The identification of new high-sensitivity and high-specificity markers for HCC are essential. We aimed to identify serum microRNAs (miRNAs) as biomarkers to be used in …
core.ac.uk
paperity.org参考文章(40)
Guochun Chen, Yan Ge, Fuyou Liu, Lin Sun, [MicroRNA-29 and fibrosis diseases]. Journal of Central South University. Medical sciences. ,vol. 36, pp. 908- 912 ,(2011) , 10.3969/J.ISSN.1672-7347.2011.09.017
Kazutoyo Morita, Akinobu Taketomi, Ken Shirabe, Kenji Umeda, Hiroto Kayashima, Mizuki Ninomiya, Hideaki Uchiyama, Yuji Soejima, Yoshihiko Maehara, Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C. Liver International. ,vol. 31, pp. 474- 484 ,(2011) , 10.1111/J.1478-3231.2010.02433.X
Jharna Datta, Huban Kutay, Mohd W. Nasser, Gerard J. Nuovo, Bo Wang, Sarmila Majumder, Chang-Gong Liu, Stefano Volinia, Carlo M. Croce, Thomas D. Schmittgen, Kalpana Ghoshal, Samson T. Jacob, Methylation Mediated Silencing of MicroRNA-1 Gene and Its Role in Hepatocellular Carcinogenesis Cancer Research. ,vol. 68, pp. 5049- 5058 ,(2008) , 10.1158/0008-5472.CAN-07-6655
Huban Kutay, Shoumei Bai, Jharna Datta, Tasneem Motiwala, Igor Pogribny, Wendy Frankel, Samson T. Jacob, Kalpana Ghoshal, Downregulation of miR‐122 in the rodent and human hepatocellular carcinomas Journal of Cellular Biochemistry. ,vol. 99, pp. 671- 678 ,(2006) , 10.1002/JCB.20982
P. Pineau, S. Volinia, K. McJunkin, A. Marchio, C. Battiston, B. Terris, V. Mazzaferro, S. W. Lowe, C. M. Croce, A. Dejean, miR-221 overexpression contributes to liver tumorigenesis Proceedings of the National Academy of Sciences of the United States of America. ,vol. 107, pp. 264- 269 ,(2010) , 10.1073/PNAS.0907904107
Silvia Cermelli, Anna Ruggieri, Jorge A. Marrero, George N. Ioannou, Laura Beretta, Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease PLoS ONE. ,vol. 6, pp. e23937- ,(2011) , 10.1371/JOURNAL.PONE.0023937
Yoshito Tomimaru, Hidetoshi Eguchi, Hiroaki Nagano, Hiroshi Wada, Shogo Kobayashi, Shigeru Marubashi, Masahiro Tanemura, Akira Tomokuni, Ichiro Takemasa, Koji Umeshita, Tatsuya Kanto, Yuichiro Doki, Masaki Mori, Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. Journal of Hepatology. ,vol. 56, pp. 167- 175 ,(2012) , 10.1016/J.JHEP.2011.04.026
Avegail Flores, Jorge A. Marrero, Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics. Clinical Medicine Insights: Oncology. ,vol. 8, pp. 71- 76 ,(2014) , 10.4137/CMO.S9926
Kevin Z. Qu, Ke Zhang, HaiRong Li, Nezam H. Afdhal, Maher Albitar, Circulating microRNAs as biomarkers for hepatocellular carcinoma. Journal of Clinical Gastroenterology. ,vol. 45, pp. 355- 360 ,(2011) , 10.1097/MCG.0B013E3181F18AC2
Fanyin Meng, Roger Henson, Hania Wehbe–Janek, Kalpana Ghoshal, Samson T. Jacob, Tushar Patel, MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer Gastroenterology. ,vol. 133, pp. 647- 658 ,(2007) , 10.1053/J.GASTRO.2007.05.022